Table 1.
Antibiotics | Resistance rate (%) | ||
---|---|---|---|
Total (n = 62) | MSSA (n = 46) | MRSA (n = 16) | |
Penicillin | 90.3 | 87.0 | 100 |
Gentamicin | 12.9 | 4.3 | 37.5 |
Kanamycin | 22.6 | 8.7 | 62.5 |
Tobramycin | 17.7 | 10.9 | 37.5 |
Erythromycin | 69.4 | 65.2 | 81.3 |
Tetracycline | 22.6 | 15.2 | 43.8 |
Minocycline | 1.6 | 0 | 6.3 |
Ciprofloxacin | 14.5 | 8.7 | 31.3 |
Clindamycin* | 14.5 | 8.7 | 31.3 |
Chloramphenicol | 4.8 | 4.3 | 6.3 |
Rifampicin | 1.6 | 0 | 6.3 |
Quinupristin-dalfopristin | 1.6 | 0 | 6.3 |
Fusidic acid | 4.8 | 0 | 6.3 |
Mupirocin† | 1.6 | 0 | 6.3 |
*35 isolates (27 MSSA and 8 MRSA) were D-test positive, indicating inducible clindamycin resistance; †One MRSA isolate presented high-level mupirocin resistance. MSSA: Methicillin-susceptible Staphylococcus aureus; MRSA: Methicillin-resistant Staphylococcus aureus.